Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.22
0.00 (0.00%)
USD |
NASDAQ |
Oct 30, 16:00
4.23
+0.01
(+0.24%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Net Income (TTM) : -101.90M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -101.90M |
| March 31, 2026 | -84.53M |
| December 31, 2025 | -78.54M |
| September 30, 2025 | -67.51M |
| June 30, 2025 | -57.95M |
| March 31, 2025 | -50.29M |
| December 31, 2024 | -40.21M |
| September 30, 2024 | -38.70M |
| June 30, 2024 | -34.97M |
| March 31, 2024 | -33.76M |
| December 31, 2023 | -44.60M |
| September 30, 2023 | -47.46M |
| June 30, 2023 | -46.19M |
| March 31, 2023 | -50.65M |
| December 31, 2022 | -42.35M |
| September 30, 2022 | -41.73M |
| June 30, 2022 | -35.12M |
| March 31, 2022 | -39.01M |
| December 31, 2021 | -45.64M |
| September 30, 2021 | -43.99M |
| June 30, 2021 | -76.71M |
| March 31, 2021 | -97.68M |
| December 31, 2020 | -111.27M |
| September 30, 2020 | -129.24M |
| June 30, 2020 | -115.13M |
| Date | Value |
|---|---|
| March 31, 2020 | -74.88M |
| December 31, 2019 | -71.45M |
| September 30, 2019 | -62.18M |
| June 30, 2019 | -55.99M |
| March 31, 2019 | -70.21M |
| December 31, 2018 | -55.67M |
| September 30, 2018 | -49.06M |
| June 30, 2018 | -41.42M |
| March 31, 2018 | -36.65M |
| December 31, 2017 | -32.42M |
| September 30, 2017 | -29.30M |
| June 30, 2017 | -27.68M |
| March 31, 2017 | -24.57M |
| December 31, 2016 | -20.00M |
| September 30, 2016 | -14.93M |
| June 30, 2016 | -11.83M |
| March 31, 2016 | -10.21M |
| December 31, 2015 | -8.851M |
| September 30, 2015 | -7.612M |
| June 30, 2015 | -6.018M |
| March 31, 2015 | -3.960M |
| December 31, 2014 | -2.540M |
| September 30, 2014 | -1.570M |
| June 30, 2014 | -0.97M |
| March 31, 2014 | -0.6748M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Heron Therapeutics, Inc. | -34.05M |
| Tonix Pharmaceuticals Holding Corp. | -159.67M |
| Karyopharm Therapeutics, Inc. | -224.74M |
| Minerva Neurosciences, Inc. | -394.35M |
| Ocugen, Inc. | -81.81M |